BRAIN Biotech AG
BNN.DE
Get informed when a big investor buys or sells
+ FollowMarket Cap$60.74M
Close$
Share Statistics
| Market cap | $60.74 Million |
|---|---|
| Enterprise Value | $59.80 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.54 |
| Beta | 0.62 |
| Outstanding Shares | 21,847,495 |
Return
| Return on Equity | 204.79% |
|---|---|
| Return on Assets | -24.55% |
| Return on Invested Capital | -26.84% |
Valuation & Multiples
| P/E Ratio | -4.21 |
|---|---|
| PEG | -0.87 |
| Price to Sales | 1.35 |
| Price to Book Ratio | -2.7 |
| Enterprise Value to Revenue | 1.01 |
| Enterprise Value to EBIT | -5 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 27, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$28.10 M
Average shareholder expectationNext Earnings Call
Expected Date
January 14, 2027
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$11.22 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About BRAIN Biotech AG
280 employees
CEO: Adriaan Moelker Headquartered in Zwingenberg, Germany, and founded in 1993, BRAIN Biotech AG (renamed from B.R.A.I.N. Biotechnology Research and Information Network AG in April 2021) specializes in the discovery, development, production, and commerciali...